Antibody–drug conjugates in advanced small-cell lung cancer: a systematic review and single-arm meta-analysis of later-line monotherapy
ObjectiveAntibody–drug conjugates (ADCs) are being investigated in advanced small-cell lung cancer (SCLC), but the evidence is dominated by early-phase studies conducted in non-exchangeable treatment settings. We evaluated the activity and toxicity of …